RTN4 and myeloid sarcoma: SCD areas of progressive MS patients showed a significant decrease of NogoA+ OLs in the superficial layers (3 + 0.8 cells/mm2, Fig. 3c) compared to adjacent normal-appearing layers I/II (p < 0.01, Fig. 3b, e).